TY - JOUR
T1 - Prevalence and Treatment Characteristics of Spastic Hypertonia on First-Time Admission to Acute Inpatient Rehabilitation
AU - Dragojlovic, Nikola
AU - Romanoski, Natasha L.
AU - Verduzco-Gutierrez, Monica
AU - Francisco, Gerard E.
N1 - Funding Information:
MV-G is a paid consultant for AbbVie/Allergan, Merz, Ipsen, Medtronic, and Piramal, and her research was funded by Ipsen. GEF received consulting honoraria and research grants from Allergan, Ekso, and Merz; research grants from Ipsen, Microtransponder, Ottobock/Hangar Orthopedics, Parker Hannifin, Rewalk, and Revance Therapeutics; and consulting honoraria from Shiniogi and Sword Health.
Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.
PY - 2022/4/1
Y1 - 2022/4/1
N2 - Objective The aim of the study was to report the prevalence of spasticity and treatment patterns during first-time admission to inpatient rehabilitation after acute stroke, traumatic brain injury, and spinal cord injury. Design This is a retrospective cohort study. Methods A review of 285 adult patients consecutively admitted to inpatient rehabilitation was conducted. Patients with a history of spasticity and inpatient rehabilitation course and those younger than 18 yrs were excluded. Main outcome measures are as follows: admitting diagnosis, length of stay, time from injury to admission, acute transfer rate, prevalence and severity of spasticity using Modified Ashworth Scale at admission and discharge, Functional Independence Measure scores at admission and discharge, Functional Independence Measure efficiency, and treatments for spasticity. Results Stroke patients had the highest prevalence of spasticity: 68% on admission and 50% at discharge. In traumatic brain injury, spasticity prevalence was 55% on admission and 30% at discharge. In spinal cord injury, spasticity prevalence was 48% on admission and 46% at discharge. Patients with spinal cord injury received the most medications to control spasticity, whereas those with traumatic brain injury and stroke received the most procedural interventions. Conclusions Spasticity is a common sequela of upper motor neuron injury for patients admitted to inpatient rehabilitation. Early recognition and management are essential to prevent contractures, minimize pain, and maximize functional recovery.
AB - Objective The aim of the study was to report the prevalence of spasticity and treatment patterns during first-time admission to inpatient rehabilitation after acute stroke, traumatic brain injury, and spinal cord injury. Design This is a retrospective cohort study. Methods A review of 285 adult patients consecutively admitted to inpatient rehabilitation was conducted. Patients with a history of spasticity and inpatient rehabilitation course and those younger than 18 yrs were excluded. Main outcome measures are as follows: admitting diagnosis, length of stay, time from injury to admission, acute transfer rate, prevalence and severity of spasticity using Modified Ashworth Scale at admission and discharge, Functional Independence Measure scores at admission and discharge, Functional Independence Measure efficiency, and treatments for spasticity. Results Stroke patients had the highest prevalence of spasticity: 68% on admission and 50% at discharge. In traumatic brain injury, spasticity prevalence was 55% on admission and 30% at discharge. In spinal cord injury, spasticity prevalence was 48% on admission and 46% at discharge. Patients with spinal cord injury received the most medications to control spasticity, whereas those with traumatic brain injury and stroke received the most procedural interventions. Conclusions Spasticity is a common sequela of upper motor neuron injury for patients admitted to inpatient rehabilitation. Early recognition and management are essential to prevent contractures, minimize pain, and maximize functional recovery.
UR - http://www.scopus.com/inward/record.url?scp=85127729543&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127729543&partnerID=8YFLogxK
U2 - 10.1097/PHM.0000000000001823
DO - 10.1097/PHM.0000000000001823
M3 - Article
C2 - 34121067
AN - SCOPUS:85127729543
SN - 0894-9115
VL - 101
SP - 348
EP - 352
JO - American Journal of Physical Medicine
JF - American Journal of Physical Medicine
IS - 4
ER -